NMIBC from intermediate to high risk: Current landscape and ongoing studies
Organised by the European School of Urology and the EAU Section of Oncological Urology, this UROwebinar will focus on the evolving management of intermediate- and high-risk non-muscle-invasive bladder cancer (NMIBC).
| Organiser | European School of Urology |
|---|---|
| CME | To be approved |
| Location | Online |
The UROwebinar aims to explain and explore the current definitions, treatment paradigms, and clinical dilemmas in daily practice.
By addressing ongoing challenges such as optimal risk stratification, treatment duration, and future therapeutic directions, the UROwebinar will help urologists make informed decisions and prepare for innovations that are likely to reshape NMIBC care in the coming years.
Faculty
Dr. M. Moschini (IT)
Dr. L.S. Mertens (NL)
Dr. M.C. Mir Maresma (ES)
Dr. F. Soria (IT)
Acknowledgement
This activity is supported by an educational grant from our industry partner, with no involvement in the programme or speaker selection.